Real Time
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,425 EUR | +1,79% | -3,39% | -64,38% |
11/04 | Brusselse beurs opent aarzelend | AM |
07/04 | Brusselse beurs begint nieuw kwartaal terughoudend | AM |
Omzet 2024 * | 650K 697K | Omzet 2025 * | 31,4 mln. 33,65 mln. | Marktkapitalisatie | 50,27 mln. 53,88 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -20 mln. -21,44 mln. | Nettowinst (verlies) 2025 * | -1 mln. -1,07 mln. | EV/omzet 2024 * | 150 x |
Nettoschuld 2024 * | 47,5 mln. 50,91 mln. | Nettoschuld 2025 * | 17,7 mln. 18,97 mln. | EV/omzet 2025 * | 2,16 x |
K/w-verhouding 2024 * |
-2,37
x | K/w-verhouding 2025 * |
-28
x | Werknemers | 70 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 76,24% |
Recentste transcriptie over Sequana Medical N.V.
1 dag | -1,06% | ||
1 week | -1,75% | ||
Lopende maand | -6,98% | ||
1 maand | -9,39% | ||
3 maanden | -56,66% | ||
6 maanden | -46,15% | ||
Lopend jaar | -65,00% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ian Crosbie
CEO | Chief Executive Officer | 56 | 01-01-16 |
Director of Finance/CFO | 50 | - | |
Andreas Wirth
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Douglas Kohrs
BRD | Director/Board Member | 66 | 19-07-22 |
Wim Ottevaere
BRD | Director/Board Member | 68 | 08-11-18 |
Ids van der Weij
BRD | Director/Board Member | - | 10/11 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
25-04-24 | 1,425 | +1,79% | 3 737 |
24-04-24 | 1,4 | -1,06% | 17 617 |
23-04-24 | 1,415 | -1,05% | 44 506 |
22-04-24 | 1,43 | -0,69% | 22 362 |
19-04-24 | 1,44 | -2,37% | 13 450 |
Real Time Euronext Bruxelles, 24 april 2024 om 17:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-65,00% | 53,72 mln. | |
+4,09% | 43,84 mld. | |
+47,81% | 41,25 mld. | |
+9,45% | 41,68 mld. | |
-10,92% | 27,04 mld. | |
+9,32% | 25,53 mld. | |
-24,87% | 18,18 mld. | |
+29,70% | 12,29 mld. | |
+1,28% | 12,29 mld. | |
+7,78% | 11,15 mld. |